Health: Clinical Trials News

Today is June 20, 2024. All times in Eastern Daylight Time.

Tubulis Doses First Patient in Phase I/IIa Trial Investigating ADC Candidate TUB-040 in Ovarian Cancer and Lung Adenocarcinoma

06/20/2024 - 05:00 AM

BUSINESS WIRE
Sensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies Implantables

06/20/2024 - 01:30 AM

BUSINESS WIRE
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies

06/20/2024 - 01:30 AM

BUSINESS WIRE
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates

06/20/2024 - 01:30 AM

BUSINESS WIRE
Takeda présente au congrès annuel de la PNS des données à long terme de l’essai clinique ADVANCE-CIDP 3 de Phase 3 portant sur l’administration de HYQVIA® à des patients atteints de polyradiculonévrite inflammatoire démyélinisante chronique (PIDC)

06/19/2024 - 01:25 PM

BUSINESS WIRE
Cessation Therapeutics Announces Oral Presentation of Preliminary Findings from First-in-Human Study of Anti-Fentanyl Monoclonal Antibody, CSX-1004

06/19/2024 - 11:30 AM

BUSINESS WIRE
Hagar Announces Published Clinical Data on GWave Technology

06/19/2024 - 11:00 AM

BUSINESS WIRE
Takeda在PNS年会上展示慢性炎症性脱髓鞘性多发性神经病(CIDP)患者使用HYQVIA®的3期ADVANCE-CIDP 3临床试验的长期数据

06/19/2024 - 10:48 AM

BUSINESS WIRE
Takeda在PNS年會上展示慢性脫髓鞘多發性神經炎(CIDP)病患使用HYQVIA®的第三期ADVANCE-CIDP 3臨床試驗的長期資料

06/19/2024 - 10:48 AM

BUSINESS WIRE
Takeda presenta datos de largo plazo del ensayo clínico de fase 3 ADVANCE-CIDP 3 de HYQVIA® en pacientes con polineuropatía desmielinizante inflamatoria crónica (PDIC) en la Reunión Anual de la PNS

06/19/2024 - 10:43 AM

BUSINESS WIRE
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

06/19/2024 - 08:00 AM

BUSINESS WIRE
Takeda apresenta dados de longo prazo do ensaio clínico de fase 3 ADVANCE-CIDP 3 de HYQVIA® em pacientes com polineuropatia desmielinizante inflamatória crônica (CIDP, ou PDIC em português) na reunião anual da PNS

06/19/2024 - 04:25 AM

BUSINESS WIRE
Takeda präsentiert Langzeitdaten der klinischen Phase-3-Studie ADVANCE-CIDP 3 mit HYQVIA® bei Patienten mit chronisch entzündlicher demyelinisierender Polyneuropathie (CIDP) auf der PNS-Jahrestagung

06/19/2024 - 04:24 AM

BUSINESS WIRE
Galderma Granted Key Manufacturing License Updates for New Biologics Capabilities at Its Center of Excellence

06/19/2024 - 01:00 AM

BUSINESS WIRE
Samenvatting: Takeda presenteert langetermijngegevens van klinische Fase 3 ADVANCE-CIDP 3- studie van HYQVIA® bij patiënten met chronische inflammatoire demyeliniserende polyneuropathie (CIDP) op de jaarlijkse bijeenkomst van PNS

06/18/2024 - 06:18 PM

BUSINESS WIRE
Riassunto: Takeda presenta i dati a lungo termine dallo studio clinico di fase 3 ADVANCE-CIDP 3 su HYQVIA ® in pazienti affetti da polineuropatia demielinizzante infiammatoria cronica (CIDP) al Convegno annuale del PNS

06/18/2024 - 06:18 PM

BUSINESS WIRE
Empatica anuncia la integración de Mobilise-D Mobility Outcomes y avanza hacia una solución unificada para los profesionales clínicos

06/18/2024 - 06:11 PM

BUSINESS WIRE
Empatica kondigt de integratie aan van Mobilise-D Mobility Outcomes, op weg naar een uniforme oplossing voor klinische professionals

06/18/2024 - 03:32 PM

BUSINESS WIRE
Empatica annuncia l'integrazione dei risultati di mobilità di Mobilise-D, promuovendo una soluzione unificata per i professionisti clinici

06/18/2024 - 03:31 PM

BUSINESS WIRE
Empatica kündigt die Integration von Mobilise-D Mobility Outcomes an und geht damit einen Schritt weiter in Richtung einer einheitlichen Lösung für klinische Fachkräfte

06/18/2024 - 03:31 PM

BUSINESS WIRE
Empatica annonce l’intégration des résultats de mobilité de Mobilise-D et pose les bases d’une solution unifiée pour les professionnels cliniques

06/18/2024 - 03:31 PM

BUSINESS WIRE
New Study Finds That Empowering Primary Care Providers with Data-Driven Cognitive Screening Tools Increases Identification of Cognitive Impairment

06/18/2024 - 01:00 PM

BUSINESS WIRE
Aptatek BioSciences, Inc. Closes Funding Tranche Based on Successful Clinical Evaluation of Its PheCheckTM Aptamer-Based In-Home Monitoring Platform

06/18/2024 - 12:46 PM

BUSINESS WIRE
メディデータ、AIを活用して臨床試験に関する最新のデータエクスペリエンスを提供するClinical Data Studioを発表

06/18/2024 - 11:50 AM

BUSINESS WIRE
Marigold Health Secures $11m in Series A Funding to Expand Peer Support

06/18/2024 - 10:11 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 32

Next »

Search